[Relationship between long non-coding RNA MALAT1 and prostate cancer].

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Prostate cancer (PCa) is a significant global health concern, particularly for elderly men.
• Research increasingly focuses on long non-coding RNAs (lncRNAs) in PCa progression and treatment.
• Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) has emerged as a key lncRNA in PCa.

Purpose of the Study:

• To review the multifaceted role of lncRNA MALAT1 in prostate cancer.
• To elucidate the mechanisms by which MALAT1 influences PCa progression, metastasis, and treatment response.
• To highlight MALAT1 as a potential therapeutic target and diagnostic marker for PCa.

Main Methods:

• Literature review of studies investigating MALAT1 in prostate cancer.
• Analysis of research on MALAT1's involvement in PCa cell proliferation, invasion, and metastasis.
• Examination of MALAT1's regulatory roles in ceRNA and AR signaling pathways relevant to PCa treatment.

Main Results:

• MALAT1 significantly impacts PCa biological characteristics, including metastasis and cell proliferation.
• MALAT1 influences the efficacy of medicinal treatments for PCa.
• Key mechanisms involve MALAT1's participation in ceRNA networks and androgen receptor (AR) signaling.

Conclusions:

• lncRNA MALAT1 is a critical factor in prostate cancer progression and treatment.
• Targeting MALAT1 may offer novel therapeutic strategies for PCa.
• Further research into MALAT1's functions can guide new diagnostic and treatment approaches for PCa.